ARCA biopharma Common Stock

ARCA biopharma (ABIO) currently reports a common stock of $61K as of June 2026. That compares with $3.1M in the prior-year period — down 98.0% year over year. Use the charts on this page to explore ARCA biopharma's common stock history and peer comparisons.

ARCA biopharma's common stock decreased from $3.1M to $61K — a 98.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ARCA biopharma reported $61K in common stock as of June 2026. That compares with $3.1M in the prior-year period — down 98.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $61K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ARCA biopharma, and consider following ABIO for alerts when major investors trade the stock.

ARCA biopharma is classified in the Healthcare sector. On common stock, it currently shows $61K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABIO with unrelated industries.